REFERENCES
- Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and out-come. Medicine (Baltimore) 2000; 79: 250–60.
- Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781–803.
- Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608–15.
- Baddley JW, Salzman D, Pappas PG. Fungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical features. Clin Transplant 2002; 16: 419–24.
- Ascioglu S, Rex JH, de Pauw B, et al. Defining oppor-tunistic invasive fungal infections in immunocompromised patients with cancer and hemopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
- Wegman TG, Lin H, Guibert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal rela-tionship: is successful pregnancy a TH-2 phenomenon? Immunol Today 1993; 14: 353–6.
- Mellor AL, Munn DH. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 2000; 18: 367–91.
- Roberts CW, Satoskar A, Alexander J. Sex steroids, pregnancy-associated hormones and immunity to parasitic infection. Parasitol Today 1996; 12: 382–7.
- Klock C, Cerski M, Dargel A, Goldani LZ. Case Report. Disseminated aspergillosis complicating pregnancy. Mycoses 2002; 45: 408–10.
- Bern Rejeb A, Boubaker S, Turki I, Massaoudi L, Chibani M., Khouja A. Placental aspergillosis: myth or reality? Apropos of a case with fetal death in utero. J Gynecol Obstet Reprod 1993; 22: 85–9.
- Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent J-L. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003; 15: 71–5.
- Steinbach WJ, Stevens DA, Denning DW. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clin Infect Dis 2003; 37: S188–S224.
- Verwej PE, Donnelly JP, Meis JFGM. High-dose itra-conazole for the treatment of cerebral aspergillosis. Clin Infect Dis 1996; 23: 1196–7.
- Sanchez C, Mauri E, Dalmau D, Quintana S, Aparicio A, Garau J. Treatment of cerebral aspergillosis with itracona-zole: do high doses improbe the diagnosis? Clin Infect Dis 1995; 21: 1485–7.
- Miyama T, Takanaga H, Matsuo H, et al. P-glycopro-tein-mediated transport of itraconazole across the blood-brain barrier. Antimicrob Agents Chemother 1998; 42: 1738–44.
- Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–15.